SEARCH

Search Details

Kuroki Kimiko

Faculty of Pharmaceutical Sciences Molecular Pharmaceutical Sciences Molecular and Cellular Biological SciencesProfessor
Institute for Integrated Innovations Institute for Vaccine Research and DevelopmentProfessor

Researcher basic information

■ Degree
  • 博士(保健学), 東京大学大学院
■ URL
researchmap URLホームページURL■ Various IDs
Researcher number
  • 90553313
J-Global ID■ Research Keywords and Fields
Research Keyword
  • ウイルスペプチド
  • 抗体医薬品
  • 構造解析
  • 分子免疫学
  • バイオ医薬品
  • 遺伝子多型産物
  • HIV Nef
  • HIV-2
  • 免疫チェックポイント
  • LILR
  • KIR
  • 免疫制御
  • HLA
  • 表面プラズモン共鳴法
  • 細胞表面受容体
  • 蛋白質間相互作用
Research Field
  • Life Science, Genome biology
  • Life Science, Pharmaceutical analytical chemistry and physicochemistry
  • Life Science, Immunology
  • Life Science, Medical biochemistry
  • Life Science, Biophysics
  • Life Science, Functional biochemistry
  • Life Science, Structural biochemistry
■ Educational Organization

Career

■ Career
Career
  • Apr. 2024 - Present
    Hokkaido University, Faculty of Pharmaceutical Sciences, 教授
  • Apr. 2018 - Mar. 2024
    北海道大学薬学研究院, 准教授
  • Jul. 2010 - Mar. 2018
    Hokkaido University, Faculty of Pharmaceutical Sciences, 助教
  • Apr. 2010 - Jun. 2010
    Hokkaido University, Faculty of Pharmaceutical Sciences, 日本学術振興会特別研究員(PD)
  • Apr. 2008 - Mar. 2010
    Kyushu University, Medical Institute of Bioregulation, 日本学術振興会特別研究員(PD)
  • Apr. 2004 - Mar. 2008
    Kyushu University, Medical Institute of Bioregulation, 学術研究員
  • Apr. 2002 - Mar. 2004
    The University of Tokyo, Graduate School of Medicine, 日本学術振興会特別研究員(DC2)
Educational Background
  • Mar. 2004, The University of Tokyo, Graduate School of Medicine, International Health
  • Mar. 1999, Tokyo University of Science, Faculty of Science and Technology, Applied Biological Science

Research activity information

■ Papers
  • Molecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2+NK cells.
    Takayuki Chikata; Kimiko Kuroki; Nozomi Kuse; Anna E Kliszczak; Wayne Paes; Nanami Tomioka; Robert Parker; Aure Aflalo; Tomohiro Akahoshi; Yu Zhang; Ryoya Yamashita; Ryuma Sakata; Hiroki Kusaka; Yosuke Watanabe; Annalisa Nicastri; Haruki Matsubara; Toyoyuki Ose; Shunsuke Kita; Shinichi Oka; Hiroyuki Gatanaga; Zhansong Lin; Nicola Ternette; Persephone Borrow; Katsumi Maenaka; Masafumi Takiguchi
    Nature communications, 16, 1, 9796, 9796, 06 Nov. 2025, [International Magazine]
    English, Scientific journal, NK cells and CD8+ T cells both contribute to HIV-1 control. These cells not only suppress HIV-1 replication, but also select HIV-1 escape mutant viruses. Most viruses bearing T cell escape mutations are expected to remain susceptible to NK cell suppression, but their inhibition by NK cells is unclear. We investigated the role of HIV-1-specific CD8+ T cells and NK cells recognizing superimposed Pol peptides in selection and control of HIV-1 mutant virus. KIR2DL2+NK cells have an enhanced ability to recognize HIV-1-infected cells after selection of Pol mutant virus by PolIY11-specific HLA-C*12:02-restricted T cells. Mass spectrometry-based immunopeptidome profiling of HIV-1-infected cells and analysis of crystal structures of TCR- and KIR2DL2-HLA-C*12:02-peptide complexes demonstrate the molecular basis for selection and recognition of the escape mutant epitope by TCR and KIR2DL2. The present study elucidates the mechanism for selection and inhibition of an HIV-1 escape virus by T cells and NK cells.
  • The strategy used by naïve anti-PEG antibodies to capture flexible and featureless PEG chains.
    Yiwei Liu; Takahiro Mori; Yusei Ito; Kimiko Kuroki; Seiichiro Hayashi; Daisuke Kohda; Taro Shimizu; Tatsuhiro Ishida; Steve R Roffler; Mika K Kaneko; Yukinari Kato; Takao Arimori; Takamasa Teramoto; Kazuhiro Takemura; Kenta Ishibashi; Yoshiki Katayama; Katsumi Maenaka; Yoshimitsu Kakuta; Akio Kitao; Takeshi Mori
    Journal of controlled release : official journal of the Controlled Release Society, 380, 396, 403, 10 Feb. 2025, [International Magazine]
    English, Scientific journal, Polyethylene glycol (PEG) is widely used as a standard stealth polymer, although the induction of anti-PEG antibodies and consequent effects have drawn attention in recent years. To date, several anti-PEG antibodies induced by PEG-modified proteins via the T cell-dependent (TD) pathway, in which affinity maturation occurs, have been reported. In contrast, structures of the naïve anti-PEG antibodies before affinity maturation have not been described in the literature. Here, to understand the details of the naïve anti-PEG antibodies capturing PEG, we studied a naïve anti-PEG antibody induced by a PEG-modified liposome in the absence of affinity maturation via the T cell-independent (TI) pathway. The mutation levels, structures as well as in vitro and in silico binding properties of TI and TD anti-PEG antibodies were compared. The TI anti-PEG antibody showed no mutation and a low binding affinity toward PEG, meanwhile, it allowed PEG chain sliding and weak interaction with the terminal group. Furthermore, the naïve anti-PEG antibodies may obtain high affinities by forming tunnel structures via minimal mutations. This research provides new insights into polymer-antibody interactions, which can facilitate the development of novel stealth polymers that can avoid antibody induction.
  • Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation.
    Chisato Yamada; Kimiko Kuroki; Naoyoshi Maeda; Hiroshi Watanabe; Ami Takahashi; Katsumi Maenaka
    Scientific reports, 15, 1, 2509, 2509, 20 Jan. 2025, [International Magazine]
    English, Scientific journal, Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule that has an immunosuppressive effect mediated by binding to immune inhibitory leukocyte immunoglobulin-like receptors (LILR) B1 and LILRB2. A conventional HLA-G isoform, HLA-G1, forms a heterotrimeric complex composed of a heavy chain (α1-α3 domains), β2-microglobulin (β2m) and a cognate peptide. One of the other isoforms, HLA-G2, lacks a α2 domain or β2m to form a nondisulfide-linked homodimer, and its ectodomain specifically binds to LILRB2 expressed in human monocytes, macrophages, and dendritic cells. The administration of the ectodomain of HLA-G2, designated the soluble HLA-G2 homodimer, showed significant immunosuppressive effects in mouse models of rheumatoid arthritis and systemic lupus erythematosus, presumably by binding to a mouse ortholog of LILRB2, paired immunoglobulin-like receptor B. However, the refolded soluble HLA-G2 homodimer used in these studies tends to aggregate and degrade; thus, its stability for clinical use has been a concern. In the present study, we improved the stability of the refolded soluble HLA-G2 homodimer via a site-directed PEGylation method. PEGylation at an original free cysteine residue, Cys42, resulted in increased lyophilization and thermal and serum stability. Furthermore, the PEGylated soluble HLA-G2 homodimer could better suppress atopic symptoms in mice than the non-PEGylated homodimer. These results suggest that PEGylated soluble HLA-G2 homodimers could be candidates for immunosuppressive biologics that specifically target LILRB2-positive myelomonocytic antigen-presenting cells.
  • Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination.
    Hideo Fukuhara; Kohei Yumoto; Miyuki Sako; Mizuho Kajikawa; Toyoyuki Ose; Mihiro Kawamura; Mei Yoda; Surui Chen; Yuri Ito; Shin Takeda; Mwila Mwaba; Jiaqi Wang; Takao Hashiguchi; Jun Kamishikiryo; Nobuo Maita; Chihiro Kitatsuji; Makoto Takeda; Kimiko Kuroki; Katsumi Maenaka
    eLife, 12, 24 Jul. 2024, [International Magazine]
    English, Scientific journal, Canine distemper virus (CDV) belongs to morbillivirus, including measles virus (MeV) and rinderpest virus, which causes serious immunological and neurological disorders in carnivores, including dogs and rhesus monkeys, as recently reported, but their vaccines are highly effective. The attachment glycoprotein hemagglutinin (CDV-H) at the CDV surface utilizes signaling lymphocyte activation molecule (SLAM) and Nectin-4 (also called poliovirus-receptor-like-4; PVRL4) as entry receptors. Although fusion models have been proposed, the molecular mechanism of morbillivirus fusion entry is poorly understood. Here, we determined the crystal structure of the globular head domain of CDV-H vaccine strain at 3.2 Å resolution, revealing that CDV-H exhibits a highly tilted homodimeric form with a six-bladed β-propeller fold. While the predicted Nectin-4-binding site is well conserved with that of MeV-H, that of SLAM is similar but partially different, which is expected to contribute to host specificity. Five N-linked sugars covered a broad area of the CDV-H surface to expose receptor-binding sites only, supporting the effective production of neutralizing antibodies. These features are common to MeV-H, although the glycosylation sites are completely different. Furthermore, real-time observation using high-speed atomic force microscopy revealed highly mobile features of the CDV-H dimeric head via the connector region. These results suggest that sugar-shielded tilted homodimeric structure and dynamic conformational changes are common characteristics of morbilliviruses and ensure effective fusion entry and vaccination.
  • Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    Takayuki Chikata; Wayne Paes; Nozomi Kuse; Thomas Partridge; Hiroyuki Gatanaga; Yu Zhang; Kimiko Kuroki; Katsumi Maenaka; Nicola Ternette; Shinichi Oka; Persephone Borrow; Masafumi Takiguchi
    Journal of virology, 96, 10, e0043222, 25 May 2022, [International Magazine]
    English, Scientific journal, There is increasing evidence for the importance of human leukocyte antigen C (HLA-C)-restricted CD8+ T cells in HIV-1 control, but these responses are relatively poorly investigated. The number of HLA-C-restricted HIV-1 epitopes identified is much smaller than those of HLA-A-restricted or HLA-B-restricted ones. Here, we utilized a mass spectrometry-based approach to identify HIV-1 peptides presented by HLA-C*14:03 protective and HLA-C*14:02 nonprotective alleles. We identified 25 8- to 11-mer HLA-I-bound HIV-1 peptides from HIV-1-infected HLA-C*14:02+/14:03+ cells. Analysis of T cell responses to these peptides identified novel 6 T cell epitopes targeted in HIV-1-infected HLA-C*14:02+/14:03+ subjects. Analyses using HLA stabilization assays demonstrated that all 6 epitope peptides exhibited higher binding to and greater cell surface stabilization of HLA-C*14:02 than HLA-C*14:03. T cell response magnitudes were typically higher in HLA-C*14:02+ than HLA-C*14:03+ individuals, with responses to the Pol KM9 and Nef epitopes being significantly higher. The results show that HLA-C*14:02 can elicit stronger T cell responses to HIV-1 than HLA-C*14:03 and suggest that the single amino acid difference between these HLA-C14 subtypes at position 21, outside the peptide-binding groove, indirectly influences the stability of peptide-HLA-C*14 complexes and induction/expansion of HIV-specific T cells. Taken together with a previous finding that KIR2DL2+ NK cells recognized HLA-C*14:03+ HIV-1-infected cells more than HLA-C*14:02+ ones, the present study indicates that these HLA-C*14 subtypes differentially impact HIV-1 control by T cells and NK cells. IMPORTANCE Some human leukocyte antigen (HLA) class I alleles are associated with good clinical outcomes in HIV-1 infection and are called protective HLA alleles. Identification of T cell epitopes restricted by protective HLA alleles can give important insight into virus-immune system interactions and inform design of immune-based prophylactic/therapeutic strategies. Although epitopes restricted by many protective HLA-A/B alleles have been identified, protective HLA-C alleles are relatively understudied. Here, we identified 6 novel T cell epitopes presented by both HLA-C*14:02 (no association with protection) and HLA-C*14:03 (protective) using a mass spectrometry-based immunopeptidome profiling approach. We found that these peptides bound to and stabilized HLA-C*14:02 better than HLA-C*14:03 and observed differences in induction/expansion of epitope-specific T cell responses in HIV-infected HLA-C*14:02+ versus HLA-C*14:03+ individuals. These results enhance understanding of how the microstructural difference at position 21 between these HLA-C*14 subtypes may influence cellular immune responses involved in viral control in HIV-1 infection.
  • Low-Cost Cell-Surface-Mimic Analysis of Ligand Interactions of Biotinylated Immune Receptors Using Surface Plasmon Resonance.
    Kimiko Kuroki; Hideo Fukuhara; Takashi Tadokoro; Katsumi Maenaka
    Methods in molecular biology (Clifton, N.J.), 2421, 21, 35, 2022, [International Magazine]
    English, Scientific journal, On the immune cell surface, many immune receptors are expressed and modulate the inhibitory or activating signals to control the immune responses. Recently, some of these receptors have been categorized as immune checkpoint receptors and targeted for cancer immunity or autoimmune diseases. To analyze the weak and fast binding typical for immune receptor-ligand interactions, a real-time surface plasmon resonance (SPR) technique is useful. However, it sometimes becomes difficult to optimize the immobilization conditions and appropriate controls. Considering that receptor orientation is relevant for achieving function on the cell surface, it is important to immobilize ligand proteins using specific tags at the membrane proximal end to avoid steric hindrance and structural changes in specific binding regions. Here we introduce a sensor chip, Sensor Chip CAP (Cytiva), which enables reversible and orientation-controlled immobilization of biotinylated ligands, resulting in a significant cost-effective method. We further show preparation methods of several biotinylated immune receptor proteins for SPR analysis, which are also useful for structural and other functional analyses.
  • Ca2+ Regulates ERp57-Calnexin Complex Formation
    Yuya Tanikawa; Shingo Kanemura; Dai Ito; Yuxi Lin; Motonori Matsusaki; Kimiko Kuroki; Hiroshi Yamaguchi; Katsumi Maenaka; Young-Ho Lee; Kenji Inaba; Masaki Okumura
    Molecules, 26, 10, 2853, 2853, MDPI AG, 11 May 2021, [Peer-reviewed], [Invited], [International Magazine]
    English, Scientific journal, ERp57, a member of the protein disulfide isomerase family, is a ubiquitous disulfide catalyst that functions in the oxidative folding of various clients in the mammalian endoplasmic reticulum (ER). In concert with ER lectin-like chaperones calnexin and calreticulin (CNX/CRT), ERp57 functions in virtually all folding stages from co-translation to post-translation, and thus plays a critical role in maintaining protein homeostasis, with direct implication for pathology. Here, we present mechanisms by which Ca2+ regulates the formation of the ERp57-calnexin complex. Biochemical and isothermal titration calorimetry analyses revealed that ERp57 strongly interacts with CNX via a non-covalent bond in the absence of Ca2+. The ERp57-CNX complex not only promoted the oxidative folding of human leukocyte antigen heavy chains, but also inhibited client aggregation. These results suggest that this complex performs both enzymatic and chaperoning functions under abnormal physiological conditions, such as Ca2+ depletion, to effectively guide proper oxidative protein folding. The findings shed light on the molecular mechanisms underpinning crosstalk between the chaperone network and Ca2+.
  • Efficient preparation of human and mouse CD1d proteins using silkworm baculovirus expression system.
    Hiroki Kusaka; Shunsuke Kita; Takashi Tadokoro; Kouki Yoshida; Yoshiyuki Kasai; Harumi Niiyama; Yukari Fujimoto; Shinya Hanashima; Michio Murata; Shigeru Sugiyama; Toyoyuki Ose; Kimiko Kuroki; Katsumi Maenaka
    Protein expression and purification, 172, 105631, 105631, Aug. 2020, [Peer-reviewed], [International Magazine]
    English, Scientific journal, CD1d is a major histocompatibility complex (MHC) class I-like glycoprotein and binds to glycolipid antigens that are recognized by natural killer T (NKT) cells. To date, our understanding of the structural basis for glycolipid binding and receptor recognition of CD1d is still limited. Here, we established a preparation method for the ectodomain of human and mouse CD1d using a silkworm-baculovirus expression system. The co-expression of human and mouse CD1d and β2-microglobulin (β2m) in the silkworm-baculovirus system was successful, but the yield of human CD1d was low. A construct of human CD1d fused with β2m via a flexible GS linker as a single polypeptide was prepared to improve protein yield. The production of this single-chained complex was higher (50 μg/larva) than that of the co-expression complex. Furthermore, differential scanning calorimetry revealed that the linker made the CD1d complex more stable and homogenous. These results suggest that the silkworm-baculovirus expression system is useful for structural and biophysical studies of CD1d in several aspects including low cost, easy handling, biohazard-free, rapid, and high yielding.
  • Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice.
    Hiroshi Watanabe; Kimiko Kuroki; Chisato Yamada; Yukari Saburi; Naoyoshi Maeda; Katsumi Maenaka
    Human immunology, 81, 4, 186, 190, Apr. 2020, [Peer-reviewed], [International Magazine]
    English, Human leukocyte antigen (HLA)-G, a non-classical HLA class I molecule, has one of the splicing isoforms, HLA-G2, which lacks one domain (α2) and forms a non-covalent homodimer. HLA-G2 is expressed on placental cells, regulatory T cells, tumor cells, and virus-infected cells, and is involved in immunosuppression. The major isoform of HLA-G, HLA-G1, binds to leukocyte immunoglobulin (Ig)-like receptor (LILR) B1 and LILRB2, on the contrary, HLA-G2 binds to only LILRB2. We previously reported that HLA-G2 bound LILRB2 more strongly than HLA-G1 and also to paired Ig-like receptor (PIR)-B, a mouse homolog of LILRBs. Furthermore, HLA-G2 showed immunosuppressive effects in both collagen-induced arthritis (CIA) and atopic dermatitis-like model mice. In this study, we examine in vivo effects of HLA-G2 in systemic lupus erythematosus (SLE) model mice. HLA-G2 showed the suppression of the typical SLE symptoms such as serum anti-dsDNA antibody level and urinary albumin index. Furthermore, HLA-G2 tended to downregulate B-lymphocyte stimulator (BLyS) production. This is the first observation of the immunosuppressive effects of HLA-G2 isoform in SLE model mice, suggesting that HLA-G2 could be a useful therapeutic agent for SLE.
  • Structure of HIV-2 Nef Reveals Features Distinct from HIV-1 Involved in Immune Regulation.
    Kengo Hirao; Sophie Andrews; Kimiko Kuroki; Hiroki Kusaka; Takashi Tadokoro; Shunsuke Kita; Toyoyuki Ose; Sarah L Rowland-Jones; Katsumi Maenaka
    iScience, 23, 1, 100758, 100758, 24 Jan. 2020, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, The human immunodeficiency virus (HIV) accessory protein Nef plays a major role in establishing and maintaining infection, particularly through immune evasion. Many HIV-2-infected people experience long-term viral control and survival, resembling HIV-1 elite control. HIV-2 Nef has overlapping but also distinct functions from HIV-1 Nef. Here we report the crystal structure of HIV-2 Nef core. The di-leucine sorting motif forms a helix bound to neighboring molecules, and moreover, isothermal titration calorimetry demonstrated that the CD3 endocytosis motif can directly bind to HIV-2 Nef, ensuring AP-2-mediated endocytosis for CD3. The highly conserved C-terminal region forms a α-helix, absent from HIV-1. We further determined the structure of simian immunodeficiency virus (SIV) Nef harboring this region, demonstrating similar C-terminal α-helix, which may contribute to AP-1 binding for MHC-I downregulation. These results provide insights into the distinct pathogenesis of HIV-2 infection.
  • Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.
    Kimiko Kuroki; Haruki Matsubara; Ryo Kanda; Naoyuki Miyashita; Mitsunori Shiroishi; Yuko Fukunaga; Jun Kamishikiryo; Atsushi Fukunaga; Hideo Fukuhara; Kaoru Hirose; Joan S Hunt; Yuji Sugita; Shunsuke Kita; Toyoyuki Ose; Katsumi Maenaka
    Journal of immunology (Baltimore, Md. : 1950), 203, 12, 3386, 3394, 15 Dec. 2019, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal, Human leukocyte Ig-like receptors (LILR) LILRB1 and LILRB2 are immune checkpoint receptors that regulate a wide range of physiological responses by binding to diverse ligands, including HLA-G. HLA-G is exclusively expressed in the placenta, some immunoregulatory cells, and tumors and has several unique isoforms. However, the recognition of HLA-G isoforms by LILRs is poorly understood. In this study, we characterized LILR binding to the β2-microglobulin (β2m)-free HLA-G1 isoform, which is synthesized by placental trophoblast cells and tends to dimerize and multimerize. The multimerized β2m-free HLA-G1 dimer lacked detectable affinity for LILRB1, but bound strongly to LILRB2. We also determined the crystal structure of the LILRB1 and HLA-G1 complex, which adopted the typical structure of a classical HLA class I complex. LILRB1 exhibits flexible binding modes with the α3 domain, but maintains tight contacts with β2m, thus accounting for β2m-dependent binding. Notably, both LILRB1 and B2 are oriented at suitable angles to permit efficient signaling upon complex formation with HLA-G1 dimers. These structural and functional features of ligand recognition by LILRs provide novel insights into their important roles in the biological regulations.
  • Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward Available Antibodies: Implications of Structural Characteristics of HLA-G Isoforms.
    Atsushi Furukawa; Manami Meguro; Rika Yamazaki; Hiroshi Watanabe; Ami Takahashi; Kimiko Kuroki; Katsumi Maenaka
    International journal of molecular sciences, 20, 23, 26 Nov. 2019, [Peer-reviewed], [International Magazine]
    English, The human leucocyte antigen (HLA)-G, which consists of seven splice variants, is a tolerogenic immune checkpoint molecule. It plays an important role in the protection of the fetus from the maternal immune response by binding to inhibitory receptors, including leukocyte Ig-like receptors (LILRs). Recent studies have also revealed that HLA-G is involved in the progression of cancer cells and the protection from autoimmune diseases. In contrast to its well characterized isoform, HLA-G1, the binding activities of other major HLA-G isoforms, such as HLA-G2, toward available anti-HLA-G antibodies are only partially understood. Here, we investigate the binding specificities of anti-HLA-G antibodies by using surface plasmon resonance. MEM-G9 and G233 showed strong affinities to HLA-G1, with a nM range for their dissociation constants, but did not show affinities to HLA-G2. The disulfide-linker HLA-G1 dimer further exhibited significant avidity effects. On the other hand, 4H84 and MEM-G1, which can be used for the Western blotting of HLA-G isoforms, can bind to native HLA-G2, while MEM-G9 and G233 cannot. These results reveal that HLA-G2 has a partially intrinsically disordered structure. Furthermore, MEM-G1, but not 4H84, competes with the LILRB2 binding of HLA-G2. These results provide novel insight into the functional characterization of HLA-G isoforms and their detection systems.
  • Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species.
    Hideo Fukuhara; Yuri Ito; Miyuki Sako; Mizuho Kajikawa; Koki Yoshida; Fumio Seki; Mwila Hilton Mwaba; Takao Hashiguchi; Masa-Aki Higashibata; Toyoyuki Ose; Kimiko Kuroki; Makoto Takeda; Katsumi Maenaka
    Viruses, 11, 8, 19 Aug. 2019, [Peer-reviewed], [International Magazine]
    English, Measles virus (MV) and canine distemper virus (CDV) are highly contagious and deadly, forming part of the morbillivirus genus. The receptor recognition by morbillivirus hemagglutinin (H) is important for determining tissue tropism and host range. Recent reports largely urge caution as regards to the potential expansion of host specificities of morbilliviruses. Nonetheless, the receptor-binding potential in different species of morbillivirus H proteins is largely unknown. Herein, we show that the CDV-H protein binds to the dog signaling lymphocyte activation molecule (SLAM), but not to the human, tamarin, or mouse SLAM. In contrast, MV-H can bind to human, tamarin and dog SLAM, but not to that of mice. Notably, MV binding to dog SLAM showed a lower affinity and faster kinetics than that of human SLAM, and MV exhibits a similar entry activity in dog SLAM- and human SLAM-expressing Vero cells. The mutagenesis study using a fusion assay, based on the MV-H-SLAM complex structure, revealed differences in tolerance for the receptor specificity between MV-H and CDV-H. These results provide insights into H-SLAM specificity related to potential host expansion.
  • Crystal structure of the complex between venom toxin and serum inhibitor from Viperidae snake.
    Narumi Shioi; Takashi Tadokoro; Seijiro Shioi; Yuki Okabe; Haruki Matsubara; Shunsuke Kita; Toyoyuki Ose; Kimiko Kuroki; Shigeyuki Terada; Katsumi Maenaka
    The Journal of biological chemistry, 294, 4, 1250, 1256, 25 Jan. 2019, [Peer-reviewed], [International Magazine]
    English, Venomous snakes have endogenous proteins that neutralize the toxicity of their venom components. We previously identified five small serum proteins (SSP-1-SSP-5) from a highly venomous snake belonging to the family Viperidae as inhibitors of various toxins from snake venom. The endogenous inhibitors belong to the prostate secretory protein of 94 amino acids (PSP94) family. SSP-2 interacts with triflin, which is a member of the cysteine-rich secretory protein (CRISP) family that blocks smooth muscle contraction. However, the structural basis for the interaction and the biological roles of these inhibitors are largely unknown. Here, we determined the crystal structure of the SSP-2-triflin complex at 2.3 Å resolution. A concave region centrally located in the N-terminal domain of triflin is fully occupied by the terminal β-strands of SSP-2. SSP-2 does not bind tightly to the C-terminal cysteine-rich domain of triflin; this domain is thought to be responsible for its channel-blocker function. Instead, the cysteine-rich domain is tilted 7.7° upon binding to SSP-2, and the inhibitor appears to sterically hinder triflin binding to calcium channels. These results help explain how an endogenous inhibitor prevents the venomous protein from maintaining homeostasis in the host. Furthermore, this interaction also sheds light on the binding interface between the human homologues PSP94 and CRISP-3, which are up-regulated in prostate and ovarian cancers.
  • Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILR alpha immune cell receptor
    Atsushi Furukawa; Kosuke Kakita; Tomoki Yamada; Mikihiro Ishizuka; Jiro Sakamoto; Nanao Hatori; Naoyoshi Maeda; Fumina Ohsaka; Takashi Saitoh; Takao Nomura; Kimiko Kuroki; Hisanori Nambu; Hisashi Arase; Shigeki Matsunaga; Masahiro Anada; Toyoyuki Ose; Shunichi Hashimoto; Katsumi Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 292, 51, 21128, 21136, Dec. 2017, [Peer-reviewed]
    English, Scientific journal
  • Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice
    Naoyoshi Maeda; Chisato Yamada; Ami Takahashi; Kimiko Kuroki; Katsumi Maenaka
    INTERNATIONAL IMMUNOPHARMACOLOGY, 50, 202, 207, Sep. 2017, [Peer-reviewed]
    English, Scientific journal
  • Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer
    Kimiko Kuroki; Kazuhiro Mio; Ami Takahashi; Haruki Matsubara; Yoshiyuki Kasai; Sachie Manaka; Masahide Kikkawa; Daizo Hamada; Chikara Sato; Katsumi Maenaka
    JOURNAL OF IMMUNOLOGY, 198, 9, 3399, 3403, May 2017, [Peer-reviewed]
    English, Scientific journal
  • Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection
    Naoyoshi Maeda; Atsushi Furukawa; Kosuke Kakita; Masahiro Anada; Shunichi Hashimoto; Shigeki Matsunaga; Kimiko Kuroki; Toyoyuki Ose; Akihisa Kato; Jun Arii; Yasushi Kawaguchi; Hisashi Arase; Katsumi Maenaka
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 39, 11, 1897, 1902, Nov. 2016, [Peer-reviewed]
    English, Scientific journal
  • HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03
    Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
    CELL REPORTS, 17, 9, 2210, 2220, Nov. 2016, [Peer-reviewed]
    English, Scientific journal
  • The immunosuppressive effect of domain-deleted dimer of HLA-G2 isoform in collagen-induced arthritis mice
    Ami Takahashi; Kimiko Kuroki; Yuki Okabe; Yoshiyuki Kasai; Naoki Matsumoto; Chisato Yamada; Toshiyuki Takai; Toyoyuki Ose; Shigeyuki Kon; Tadashi Matsuda; Katsumi Maenaka
    HUMAN IMMUNOLOGY, 77, 9, 754, 759, Sep. 2016, [Peer-reviewed]
    English, Scientific journal
  • Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes
    Yuichiro Fujieda; Olga Amengual; Masaki Matsumoto; Kimiko Kuroki; Hidehisa Takahashi; Michihito Kono; Takashi Kurita; Kotaro Otomo; Masaru Kato; Kenji Oku; Toshiyuki Bohgaki; Tetsuya Horita; Shinsuke Yasuda; Katsumi Maenaka; Shigetsugu Hatakeyama; Keiichi I. Nakayama; Tatsuya Atsumi
    RHEUMATOLOGY, 55, 6, 1117, 1126, Jun. 2016, [Peer-reviewed]
    English, Scientific journal
  • Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administration
    Hidetaka Akita; Taichi Nakatani; Kimiko Kuroki; Katsumi Maenaka; Kota Tange; Yuta Nakai; Hideyoshi Harashima
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 490, 1-2, 142, 145, Jul. 2015, [Peer-reviewed]
    English, Scientific journal
  • Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A
    Shunsuke Kita; Haruki Matsubara; Yoshiyuki Kasai; Takaharu Tamaoki; Yuki Okabe; Hideo Fukuhara; Jun Kamishikiryo; Elena Krayukhina; Susumu Uchiyama; Toyoyuki Ose; Kimiko Kuroki; Katsumi Maenaka
    EUROPEAN JOURNAL OF IMMUNOLOGY, 45, 6, 1605, 1613, Jun. 2015, [Peer-reviewed]
    English, Scientific journal
  • Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILR alpha
    Kimiko Kuroki; Jing Wang; Toyoyuki Ose; Munechika Yamaguchi; Shigekazu Tabata; Nobuo Maita; Seiko Nakamura; Mizuho Kajikawa; Amane Kogure; Takeshi Satoh; Hisashi Arase; Katsumi Maenaka
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 111, 24, 8877, 8882, Jun. 2014, [Peer-reviewed]
    English, Scientific journal
  • NKG2D Triggers Cytotoxicity in Murine Epidermal gamma delta T Cells via PI3K-Dependent, Syk/ZAP70-Independent Signaling Pathway
    Atsuko Ibusuki; Kazuhiro Kawai; Shigeru Yoshida; Youhei Uchida; Ayano Nitahara-Takeuchi; Kimiko Kuroki; Mizuho Kajikawa; Toyoyuki Ose; Katsumi Maenaka; Masanori Kasahara; Takuro Kanekura
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, 2, 396, 404, Feb. 2014, [Peer-reviewed]
    English, Scientific journal
  • Allosteric Regulation of Epoxide Opening Cascades by a Pair of Epoxide Hydrolases in Monensin Biosynthesis
    Atsushi Minami; Toyoyuki Ose; Kyohei Sato; Azusa Oikawa; Kimiko Kuroki; Katsumi Maenaka; Hiroki Oguri; Hideaki Oikawa
    ACS CHEMICAL BIOLOGY, 9, 2, 562, 569, Feb. 2014, [Peer-reviewed]
    English, Scientific journal
  • 1P005 Structure analysis of lectin-like transcript 1 (LLT1) and model building of LLT1-CD161 complex(Protein: Structure,Poster,The 52th Annual Meeting of the Biophysical Society of Japan(BSJ2014))
    Shunsuke Kita; Haruki Matsubara; Jun Kamishikiryo; Yuki Okabe; Hideo Fukuhara; Kimiko Kuroki; Katsumi Maenaka
    Seibutsu Butsuri, 54, 1, S141, The Biophysical Society of Japan General Incorporated Association, 2014
    English
  • Structural and functional mosaic nature of MHC class I molecules in their peptide-free form
    Eiji Kurimoto; Kimiko Kuroki; Yoshiki Yamaguchi; Maho Yagi-Utsumi; Takahiro Igaki; Takeshi Iguchi; Katsumi Maenaka; Koichi Kato
    Molecular Immunology, 55, 3-4, 393, 399, Oct. 2013, [Peer-reviewed]
    English, Scientific journal
  • The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis
    Kimiko Kuroki; Kaoru Hirose; Yuki Okabe; Yuko Fukunaga; Ami Takahashi; Mitsunori Shiroishi; Mizuho Kajikawa; Shigekazu Tabata; Seiko Nakamura; Toshiyuki Takai; Satoru Koyanagi; Shigehiro Ohdo; Katsumi Maenaka
    HUMAN IMMUNOLOGY, 74, 4, 433, 438, Apr. 2013, [Peer-reviewed]
    English, Scientific journal
  • Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity
    Yuichi Yagita; Nozomi Kuse; Kimiko Kuroki; Hiroyuki Gatanaga; Jonathan M. Carlson; Takayuki Chikata; Zabrina L. Brumme; Hayato Murakoshi; Tomohiro Akahoshi; Nico Pfeifer; Simon Mallal; Mina John; Toyoyuki Ose; Haruki Matsubara; Ryo Kanda; Yuko Fukunaga; Kazutaka Honda; Yuka Kawashima; Yasuo Ariumi; Shinichi Oka; Katsumi Maenaka; Masafumi Takiguchi
    JOURNAL OF VIROLOGY, 87, 4, 2253, 2263, Feb. 2013, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
  • 3P006 Three dimensional reconstruction of HLA-G2/G6 isoform(01A. Protein: Structure,Poster)
    Mio Kazuhiro; Kuroki Kimiko; Matsubara Haruki; Kasai Yoshiyuki; Sato Chikara; Maenaka Katsumi
    Seibutsu Butsuri, 53, 1, S212, The Biophysical Society of Japan General Incorporated Association, 2013
    English
  • Ribophorin II Is Involved in the Tissue Factor Expression Mediated by Phosphatidylserine-Dependent Antiprothrombin Antibody On Monocytes.
    Yuichiro Fujieda; Olga Amengual; Yusaku Kanetsuka; Toshio Odani; Kotaro Otomo; Kenji Oku; Toshiyuki Bohgaki; Tetsuya Horita; Shinsuke Yasuda; Kimiko Kuroki; Katsumi Maenaka; Masaki Matsumoto; Shigetsugu Hatakeyama; Tatsuya Atsumi
    ARTHRITIS AND RHEUMATISM, 64, 10, S741, S741, Oct. 2012, [Peer-reviewed]
    English
  • Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis
    Sravan K. Payeli; Simon Kollnberger; Osiris Marroquin Belaunzaran; Markus Thiel; Kirsty McHugh; Joanna Giles; Jacqueline Shaw; Sascha Kleber; Anna Ridley; Isabel Wong-Baeza; Sarah Keidel; Kimiko Kuroki; Katsumi Maenaka; Andreas Wadle; Christoph Renner; Paul Bowness
    ARTHRITIS AND RHEUMATISM, 64, 10, 3139, 3149, Oct. 2012, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
  • HLA-B27 Homodimers and Free H Chains Are Stronger Ligands for Leukocyte Ig-like Receptor B2 than Classical HLA Class I
    Joanna Giles; Jackie Shaw; Christopher Piper; Isabel Wong-Baeza; Kirsty McHugh; Anna Ridley; Demin Li; Izabela Lenart; Antony N. Antoniou; Katilin DiGleria; Kimiko Kuroki; Katsumi Maenaka; Paul Bowness; Simon Kollnberger
    JOURNAL OF IMMUNOLOGY, 188, 12, 6184, 6193, Jun. 2012, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
  • Molecular recognition of paired receptors in the immune system
    Kimiko Kuroki; Atsushi Furukawa; Katsumi Maenaka
    FRONTIERS IN MICROBIOLOGY, 3, 429, 2012, [Peer-reviewed]
    English
  • Molecular Basis for Herpesvirus Entry Mediator Recognition by the Human Immune Inhibitory Receptor CD160 and Its Relationship to the Cosignaling Molecules BTLA and LIGHT
    Rieko Kojima; Mizuho Kajikawa; Mitsunori Shiroishi; Kimiko Kuroki; Katsumi Maenaka
    JOURNAL OF MOLECULAR BIOLOGY, 413, 4, 762, 772, Nov. 2011, [Peer-reviewed]
    English, Scientific journal
  • Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein (NKRP1A/KLRB1)
    Jun Kamishikiryo; Hideo Fukuhara; Yuki Okabe; Kimiko Kuroki; Katsumi Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 286, 27, 23823, 23830, Jul. 2011, [Peer-reviewed]
    English, Scientific journal
  • Differential but Competitive Binding of Nogo Protein and Class I Major Histocompatibility Complex (MHCI) to the PIR-B Ectodomain Provides an Inhibition of Cells
    Haruka Matsushita; Shota Endo; Eiji Kobayashi; Yuzuru Sakamoto; Keisuke Kobayashi; Kohji Kitaguchi; Kimiko Kuroki; Arvid Soderhall; Katsumi Maenaka; Akira Nakamura; Stephen M. Strittmatter; Toshiyuki Takai
    JOURNAL OF BIOLOGICAL CHEMISTRY, 286, 29, 25739, 25747, Jul. 2011, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
  • Analysis of receptor-ligand interactions by surface plasmon resonance.
    Kuroki K; Maenaka K
    Methods in molecular biology (Clifton, N.J.), 748, 83, 106, 2011, [Peer-reviewed]
  • Structures and molecular recognition for leukocyte immunoglobulin-like receptor family
    Kimiko Kuroki; Katsumi Maenaka
    Seikagaku, 83, 8, 715, 726, 2011, [Peer-reviewed]
    Japanese, Scientific journal
  • Importance of the Hydrogen Bonding Network Including Asp52 for Catalysis, as Revealed by Asn59 Mutant Hen Egg-white Lysozymes
    Toyoyuki Ose; Kimiko Kuroki; Masaaki Matsushima; Katsumi Maenaka; Izumi Kumagai
    JOURNAL OF BIOCHEMISTRY, 146, 5, 651, 657, Nov. 2009, [Peer-reviewed]
    English, Scientific journal
  • Molecular Basis for E-cadherin Recognition by Killer Cell Lectin-like Receptor G1 (KLRG1)
    Seiko Nakamura; Kimiko Kuroki; Izuru Ohki; Kaori Sasaki; Mizuho Kajikawa; Takuma Maruyama; Masayuki Ito; Yosuke Kameda; Mitsuhiko Ikura; Kazuo Yamamoto; Naoki Matsumoto; Katsumi Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 284, 40, 27327, 27335, Oct. 2009, [Peer-reviewed]
    English, Scientific journal
  • Silkworm expression and sugar profiling of human immune cell surface receptor, KIR2DL1.
    Kaori Sasaki; Mizuho Kajikawa; Kimiko Kuroki; Tomoko Motohashi; Tsukasa Shimojima; Enoch Y Park; Sachiko Kondo; Hirokazu Yagi; Koichi Kato; Katsumi Maenaka
    Biochemical and biophysical research communications, 387, 3, 575, 80, 25 Sep. 2009, [Peer-reviewed], [International Magazine]
    English, Immune cell surface receptors are directly involved in human diseases, and thus represent major drug targets. However, it is generally difficult to obtain sufficient amounts of these receptors for biochemical and structural studies because they often require posttranslational modifications, especially sugar modification. Recently, we have established a bacmid expression system for the baculovirus BmNPV, which directly infects silkworms, an attractive host for the large-scale production of recombinant sugar-modified proteins. Here we produced the human immune cell surface receptor, killer cell Ig-like receptor 2DL1 (KIR2DL1), by using the BmNPV bacmid expression system, in silkworms. By the direct injection of the bacmid DNA, the recombinant KIR2DL1 protein was efficiently expressed, secreted into body fluids, and purified by Ni(2+) affinity column chromatography. We further optimized the expression conditions, and the final yield was 0.2mg/larva. The sugar profiling revealed that the N-linked sugars of the purified protein comprised very few components, two paucimannose-type oligosaccharides, Manalpha1-6Manbeta1-4GlcNAcbeta1-4GlcNAc and Manalpha1-6Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAc. This revealed that the protein product was much more homogeneous than the complex-sugar type product obtained by mammalian cell expression. The surface plasmon resonance analysis demonstrated that the purified KIR2DL1 protein exhibited specific binding to the HLA-Cw4 ligand. Moreover, the CD spectrum showed the proper secondary structure. These results clearly suggested that the silkworm expression system is quite useful for the expression of cell surface receptors that require posttranslational modifications, as well as for their structural and binding studies, due to the relatively homogeneous N-linked sugar modifications.
  • Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8(+) T cells and NK cells
    Hathairat Thananchai; Tariro Makadzange; Katsumi Maenaka; Kimiko Kuroki; Yanchun Peng; Chris Conlon; Sarah Rowland-Jones; Tao Dong
    AIDS, 23, 2, 189, 193, Jan. 2009, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
  • Enzyme-mediated protein refolding
    Jun Okada; Tatsuo Maruyama; Konomi Motomura; Kimiko Kuroki; Katsumi Maenaka; Masafumi Sakono; Masahiro Goto
    CHEMICAL COMMUNICATIONS, 46, 7197, 7199, 2009, [Peer-reviewed]
    English, Scientific journal
  • Serotriflin, a CRISP family protein with binding affinity for small serum protein-2 in snake serum
    Narumi Aoki; Akie Sakiyama; Kimiko Kuroki; Katsumi Maenaka; Daisuke Kohda; Masanobu Deshimaru; Shigeyuki Terada
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 1784, 4, 621, 628, Apr. 2008, [Peer-reviewed]
    English, Scientific journal
  • Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis
    K. Mamegano; K. Kuroki; R. Miyashita; M. Kusaoi; S. Kobayashi; K. Matsuta; K. Maenaka; M. Colonna; S. Ozaki; H. Hashimoto; Y. Takasaki; K. Tokunaga; N. Tsuchiya
    GENES AND IMMUNITY, 9, 3, 214, 223, Apr. 2008, [Peer-reviewed]
    English, Scientific journal
  • Serotriflin, a CRISP family protein with binding affinity for small serum protein-2 in snake serum.
    Aoki N; Sakiyama A; Kuroki K; Maenaka K; Kohda D; Deshimaru M; Terada S
    Biochimica et biophysica acta, 1784, 4, 621, 628, Apr. 2008, [Peer-reviewed]
  • Biophysical characterization of O-glycosylated CD99 recognition by paired ig-like type 2 receptors
    Shigekazu Tabata; Kimiko Kuroki; Jing Wang; Mizuho Kajikawa; Ikuo Shiratori; Daisuke Kohda; Hisashi Arase; Katsumi Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 283, 14, 8893, 8901, Apr. 2008, [Peer-reviewed]
    English, Scientific journal
  • Homogeneous sugar modification improves crystallization of measles virus hemagglutinin
    Takao Hashiguchi; Mizuho Kajikawa; Maita Nobuo; Makoto Takeda; Kimiko Kuroki; Kaori Sasaki; Daisuke Kohda; Yusuke Yanagi; Katsumi Maenaka
    JOURNAL OF VIROLOGICAL METHODS, 149, 1, 171, 174, Apr. 2008, [Peer-reviewed]
    English, Scientific journal
  • 3P-015 Structural analyses of β2 microglobulin in MHC complex by NMR spectroscopy(The 46th Annual Meeting of the Biophysical Society of Japan)
    Kurimoto Eiji; Yamaguchi Yoshiki; Kuroki Kimiko; Maenaka Katsumi; Kohda Daisuke; Kato Koichi
    Seibutsu Butsuri, 48, S130, The Biophysical Society of Japan General Incorporated Association, 2008
    English
  • Expression, crystallization and preliminary X-ray diffraction analysis of human paired Ig-like type 2 receptor alpha (PILR alpha)
    Shigekazu Tabata; Kimiko Kuroki; Nobuo Maita; Jing Wang; Ikuo Shiratori; Hisashi Arase; Daisuke Kohda; Katsumi Maenaka
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS, 64, Pt 1, 44, 46, Jan. 2008, [Peer-reviewed]
    English, Scientific journal
  • Crystal structure of measles virus hemagglutinin provides insight into effective vaccines
    Takao Hashiguchi; Mizuho Kajikawa; Nobuo Maita; Makoto Takeda; Kimiko Kuroki; Kaori Sasaki; Daisuke Kohda; Yusuke Yanagi; Katsumi Maenaka
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104, 49, 19535, 19540, Dec. 2007, [Peer-reviewed]
    English, Scientific journal
  • Immune modulation of HLA-G dimer in maternal-fetal interface
    Kimiko Kuroki; Katsurni Maenaka
    EUROPEAN JOURNAL OF IMMUNOLOGY, 37, 7, 1727, 1729, Jul. 2007, [Peer-reviewed]
    English
  • Structural basis for dynamic interdomain movement and RNA recognition of the selenocysteine-specific elongation factor SelB
    Toyoyuki Ose; Nicolas Soler; Linda Rasubala; Kimiko Kuroki; Daisuke Kohda; Dominique Fourmy; Satoko Yoshizawa; Katsumi Maenaka
    STRUCTURE, 15, 5, 577, 586, May 2007, [Peer-reviewed]
    English, Scientific journal
  • Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy
    Kimiko Kuroki; Sayoko Kobayashi; Mitsunori Shiroishi; Mizuho Kajikawa; Naoaki Okamoto; Daisuke Kohda; Katsumi Maenaka
    JOURNAL OF IMMUNOLOGICAL METHODS, 320, 1-2, 172, 176, Mar. 2007, [Peer-reviewed]
    English, Scientific journal
  • Diversity of human immune system multigene families and its implication in the genetic background of rheumatic diseases
    Naoyuki Tsuchiya; Chieko Kyogoku; Risa Miyashita; Kimiko Kuroki
    CURRENT MEDICINAL CHEMISTRY, 14, 4, 431, 439, 2007, [Peer-reviewed]
    English
  • Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)
    Mitsunori Shiroishi; Kimiko Kuroki; Linda Rasubala; Kouhei Tsumoto; Izumi Kumagai; Eiji Kurimoto; Koichi Kato; Daisuke Kohda; Katsumi Maenaka
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103, 44, 16412, 16417, Oct. 2006, [Peer-reviewed]
    English, Scientific journal
  • Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11)
    Mitsunori Shiroishi; Mizuho Kajikawa; Kimiko Kuroki; Toyoyuki Ose; Daisuke Kohda; Katsumi Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 281, 28, 19536, 19544, Jul. 2006, [Peer-reviewed]
    English, Scientific journal
  • Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer
    M Shiroishi; K Kuroki; T Ose; L Rasubala; Shiratori, I; H Arase; K Tsumoto; Kumagai, I; D Kohda; K Maenaka
    JOURNAL OF BIOLOGICAL CHEMISTRY, 281, 15, 10439, 10447, Apr. 2006, [Peer-reviewed]
    English, Scientific journal
  • 1P139 BmNPV expression system; Application to human natural killer cell receptors(4. Protein engineering,Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)
    Kajikawa Mizuho; Sasaki Kaori; Kuroki Kimiko; Motohashi Tomoko; Shimojima Tsukasa; Park Enoch Y.; Kohda Daisuke; Maenaka Katsumi
    Seibutsu Butsuri, 46, 2, S181, The Biophysical Society of Japan General Incorporated Association, 2006
    English
  • 1P064 Comprehensive analysis of the MHCI binding of leukocyte immunoglobulin-like receptors using surface plasmon resonance technique(2. Protein function (I),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)
    Kuroki Kimiko; Shiroishi Mitsunori; Fukunaga Yuko; Kohda Daisuke; Maenaka Katsumi
    Seibutsu Butsuri, 46, 2, S162, The Biophysical Society of Japan General Incorporated Association, 2006
    English
  • 1P076 Molecular basis for recognition of E-cadherin by killer cell-lectin like receptor, KLRG1(2. Protein function (I),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)
    Nakamura Seiko; Kuroki Kimiko; Ohki Izuru; Sasaki Kaori; Maruyama Takuma; Ito Masayuki; Ikura Mitsuhiko; Yamamoto Kazuo; Matsumoto Naoki; Kohda Daisuke; Maenaka Katsumi
    Seibutsu Butsuri, 46, 2, S165, The Biophysical Society of Japan General Incorporated Association, 2006
    English
  • 1P027 Structual and biochemical studies of MHC class I recognition by human Leukocyte Ig-like receptors(1. Protein structure and dynamics (I),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)
    Kuroki Kimiko; Shiroishi Mitsunori; Kajikawa Mizuho; Rasubala Linda; Kohda Daisuke; Maenaka Katsumi
    Seibutsu Butsuri, 46, 2, S153, The Biophysical Society of Japan General Incorporated Association, 2006
    English
  • Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j)
    M Shiroishi; K Kuroki; K Tsumoto; A Yokota; T Sasaki; K Amano; T Shimojima; Y Shirakihara; L Rasubala; PA van der Merwe; Kumagai, I; D Kohda; K Maenaka
    JOURNAL OF MOLECULAR BIOLOGY, 355, 2, 237, 248, Jan. 2006, [Peer-reviewed]
    English, Scientific journal
  • Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis
    K Kuroki; N Tsuchiya; M Shiroish; L Rasubala; Y Yamashita; K Matsuta; T Fukazawa; M Kusaoi; Y Murakami; M Takiguchi; T Juji; H Hashimoto; D Kohda; K Maenaka; K Tokunaga
    HUMAN MOLECULAR GENETICS, 14, 16, 2469, 2480, Aug. 2005, [Peer-reviewed]
    English, Scientific journal
  • Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis
    N Tsuchiya; K Kuroki; M Fujimoto; Y Murakami; TF Tedder; K Tokunaga; K Takehara; S Sato
    ARTHRITIS AND RHEUMATISM, 50, 12, 4002, 4007, Dec. 2004, [Peer-reviewed]
    English, Scientific journal
  • Molecular genetic analyses of human NKG2C (KLRC2) gene deletion
    R Miyashita; N Tsuchiya; K Hikami; K Kuroki; T Fukazawa; M Bijl; CGM Kallenberg; H Hashimoto; T Yabe; K Tokunaga
    INTERNATIONAL IMMUNOLOGY, 16, 1, 163, 168, Jan. 2004, [Peer-reviewed]
    English, Scientific journal
  • Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in Japanese
    K Kuroki; N Tsuchiya; BP Tsao; JM Grossman; T Fukazawa; K Hagiwara; H Kano; M Takazoe; T Iwata; H Hashimoto; K Tokunaga
    GENES AND IMMUNITY, 3, S21, S30, Oct. 2002, [Peer-reviewed], [Internationally co-authored]
    English, Scientific journal
■ Other Activities and Achievements
■ Syllabus
  • 医療薬学特論, 2024年, 修士課程, 生命科学院
  • 先端生物科学実験法Ⅰ, 2024年, 学士課程, 薬学部
  • 細胞生物学Ⅰ, 2024年, 学士課程, 薬学部
  • 生物物理化学, 2024年, 学士課程, 薬学部
  • 分析化学実習, 2024年, 学士課程, 薬学部
  • 物理化学実習, 2024年, 学士課程, 薬学部
  • 物理化学Ⅰ, 2024年, 学士課程, 薬学部
■ Affiliated academic society
  • JAPANESE SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS
  • THE JAPANESE SOCIETY FOR IMMUNOLOGY
  • JAPAN COLLEGE OF RHEUMATOLOGY
  • THE JAPANESE BIOCHEMICAL SOCIETY
  • THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
  • THE PHARMACEUTICAL SOCIETY OF JAPAN
■ Research Themes
  • 免疫抑制分子HLA-Gの機能理解・制御を目指した機能性抗体開発
    科学研究費助成事業
    01 Apr. 2025 - 31 Mar. 2028
    黒木 喜美子
    日本学術振興会, 基盤研究(B), 北海道大学, 25K02396
  • 免疫抑制分子HLA-Gアイソフォームを特異的に機能阻害する腫瘍治療抗体医薬品開発
    科学研究費助成事業 基盤研究(B)
    01 Apr. 2022 - 31 Mar. 2025
    黒木 喜美子
    日本学術振興会, 基盤研究(B), 北海道大学, 22H02749
  • Molecular recognition of immune inhibitory receptor, LILRB2, with HLA-G2 and various ligands
    Grants-in-Aid for Scientific Research
    01 Apr. 2018 - 31 Mar. 2021
    Kuroki Kimiko
    To identify the binding site of the receptor LILRB2 to the LILRB2 ligand proteins containing HLA-G2, I examined the binding competitivity with HLA-G1. Next, I established a method for identifying critical region using the result that LILRB2 modified at all Lysine residues cannot bind to HLA-G2. Furthermore, I prepared a series of LILRB2 mutants extensively replaced with LILRB1-type amino acids to identify HLA-G2 binding sites on LILRB2 because HLA-G2 does not bind to LILRB1. Finally, I performed an initial screening of antibodies and small- and medium-molecular compounds to regulate LILRB2 signaling.
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 18K06073
  • 強直性脊椎炎病因蛋白質HLA-B27の受容体LILRB2を介した発症機構の解明
    科学研究費助成事業 新学術領域研究(研究領域提案型)
    01 Apr. 2013 - 31 Mar. 2015
    黒木 喜美子
    本研究の目的は、HLA-B27が通常のHLA-クラスIには見られない重鎖ホモダイマーとして細胞表面に発現することに着目し、受容体との認識機構解明、創薬および治療へとつながる分子レベルでの解析を目指すことである。
    本年度は、HLA-B27重鎖ホモダイマーの受容体として、これまでに複合体の構造解析に用いていたLILRB2に加え、近年新たに同定されたKIR3DL2を用いた構造解析を行った。KIR3DL2はHEK293細胞で細胞外ドメインを発現させた。KIR3DL2とHLA-B27重鎖ホモダイマーをモル比1:1で混合し、結晶化スクリーニングを試行した。今年度内に解析可能なデータは得られなかったが、今後も引き続き異常型ホモダイマーの受容体を介した分子認識機構の解明に向けて、構造解析を継続する予定である。
    また、HLA-B27、B27重鎖ホモダイマーを用いて、シグナル伝達制御可能な化合物スクリーニング系の確立に向けて、複数の手法を試みた。その結果、通常のHLA-B27分子は示差走査熱量分析法や示差走査蛍光測定法のいずれの手法でも分子の変性点が2点あるものの、測定条件の最適化を行えば、スクリーニングの系として用いることが可能であると予想された。また、HLA-B27重鎖ホモダイマーはペプチドを提示していないため、化合物がペプチド溝に結合することにより、ペプチドレパートリーが変化し、異常な免疫反応を誘導する可能性は低いと考えたが、DMSO含有条件下での適した測定系の確立には至らなかった。今後、細胞を用いたアッセイ系についても検討していく予定である。
    日本学術振興会, 新学術領域研究(研究領域提案型), 北海道大学, 25133701
  • Structural analysis of HLA-G6 isoform bound to LILRB2 receptor
    Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)
    01 Apr. 2013 - 31 Mar. 2015
    KUROKI KIMIKO
    I performed structural and functional analysis of the HLA-G6 isoform. Electron microscopy technique revealed the three-dimensional structure of HLA-G2/G6 homodimer which resemble HLA class I and HLA class II heterodimer molecule. In addition, I examined the function of HLA-G6 isoform in CIA mice. HLA-G6 specifically bound to the mouse receptor, PIR-B, and showed significant anti-inflammatory effects in vivo.
    Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Hokkaido University, 25870019
  • 強直性脊椎炎病因蛋白質HLA-B27ホモ二量体の立体構造解析
    科学研究費助成事業 新学術領域研究(研究領域提案型)
    01 Apr. 2011 - 31 Mar. 2013
    黒木 喜美子
    本研究の目的は、B27が通常のHLAクラスIには見られない重鎖ホモダイマーとして細胞表面上に発現することに着目し、受容体との認識機構を解明し、創薬および治療へとつながる分子レベルでの解析を目指すことである。
    申請者は昨年度に引き続き、B27ホモダイマーおよびLILR受容体との相互作用について蛋白質レベルでの解析を行った。まず、オクスフォード大学の共同研究者とともに、通常のHLA-B27には結合しない、B27ホモダイマー特異的な抗体の作製を行った。今後、この抗体をB27ホモダイマーの精製や蛋白質構造の安定化等に用いていきたいと考えている。
    また、B27ホモダイマー単独および受容体LILRB2との複合体の立体構造解析を複数の手法で行った。X線結晶構造解析においては、B27ホモダイマーはペプチドを提示していないことが分かったため、ペプチドを加えずに調製したダイマー蛋白質を用いて多数の結晶化スクリーニングを試行したが、良質な結晶は得られなかった。B27ホモダイマーはβ2mを伴わないため、分子構造がゆるく、結晶化が困難である可能性が考えられたため、受容体LILRB2との複合体の結晶化を試みた。両タンパク質の混合条件を検討し、pH9でモル比1:1で混合すると凝集体を形成しにくいことが分かり、結晶化スクリーニングを試した。その結果、複数の微結晶を得たが、LILRB2単独の結晶もしくは良質でない結晶だった。今後引き続き条件検討を行う予定である。同時に電子顕微鏡解析を進めており、HLA-B27ホモダイマーが予想していたよりは均一の粒子状の蛋白質であることが分かった。今後画像解析を進め、分子全体のドメイン配向を明らかにしたいと考えている。また、NMR解析によってもLILRB2上のB27ホモダイマー相互作用部位を明らかにするために、LlRB2単独のNMRスペクトルの解析も継続する予定である。
    日本学術振興会, 新学術領域研究(研究領域提案型), 北海道大学, 23133501
  • Molecular recognition of HLA-G6 isoform with LILR family
    Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)
    2011 - 2012
    KUROKI Kimiko
    I performed the analysis at the protein level about the interaction with HLA-G6 isoform and the LILR receptor. At first I established the expression system of stable HLA-G6 protein by E.coli. In addition, I performed structural analyses of HLA-G6 and the complex with its receptor, LILRB2, by several techniques (X-ray crystallography, cryo-EM, NMR).
    Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Hokkaido University, 23770102
  • リウマチ性疾患因子HLA-B27と免疫制御受容体LILR群の分子認識
    科学研究費助成事業 特別研究員奨励費
    2008 - 2010
    福原 喜美子; 黒木 喜美子
    ヒト細胞表面抗原HLA-B27の異常型β2mフリーホモ二量体(B27_2)が、免疫制御受容体LILR群との相互作用により、リウマチ性自己免疫疾患のひとつである強直性脊椎炎(AS)を引き起こす分子認識機構を、立体構造解析の観点から明らかにすることを目的としている。
    今年度はまず、分子動力学的なLILRB2とβ2mフリーのHLAの結合シミュレーションの結果、昨年度得られたK121、Dl22に加え、新たにQ115、D118、R14、E229、D196、E232、D227-E232、V248、V194-E198がLILRB2と相互作用していることが分かった(理研・杉田、宮下博士との共同研究)。そのうち、特にR14、D118、E232はβ2mフリーのHLAの時にのみ相互作用する残基であることが分かった。このシミュレーション結果をもとに、重要な相互作用残基の同定を目指し、実験的に表面プラスモン共鳴法で解析するためにサンプルを準備した。
    また、結晶化に関しては、共同研究先(Oxford大学・Paul博士ら)が作製したB27_2特異的抗体を用いたB27_2の精製および抗体との複合体の結晶化を目指して、サンプル供与・条件の準備を引き続き行っている。ペプチド依存的にLILRB2との結合能が6倍程度変化すると報告のあったHLA-B27/ペプチド-LILRB2複合体の結晶構造解析に関しては、昨年度に引き続き、LILRB2:B272=2:1で混合したサンプルの結晶化条件の最適化(pH、塩の種類、塩濃度、PEG濃度)を進めたが、目立った改善は認められず、解析に十分な分解能を得られていない。
    今後も引き続き、リウマチ性疾患因子HLA-B27と免疫制御受容体LILR群の分子認識の解明を目指した研究を行う予定である。
    日本学術振興会, 特別研究員奨励費, 08J05335
  • 免疫系の複合疾患感受性遺伝子の同定に向けての研究
    科学研究費助成事業 特別研究員奨励費
    2002 - 2003
    黒木 喜美子
    前年度、RA、SLEを対象とした関連研究において検出したLIR1多型とRAとの有意な関連は、LIR1と連鎖不平衡にある他の近傍の遺伝子によるものである可能性も考えられた。そのため、隣接して存在するLIR6、LIR5遺伝子について、同様に多型解析、関連研究を行った。LIR6遺伝子の多型スクリーニングの結果、計24箇所のSNPsが日本人において主要な2種のハプロタイプを形成することが見出された。このうち、マイナーハプロタイプLIR6.02陽性率のSLEにおける有意な減少が見出された(P=0.02,OR=0.64)。次に、LIR5について解析を行った。多型スクリーニングにより、計29箇所の多型が検出された。LIR1、LIR6遺伝子とは対照的に、日本人における主要なハプロタイプを決定できなかった。ゆえに、RA、SLEを対象とした関連研究は、機能的に重要であると予想される多型について行った。その結果、最終的に-965G>A多型、Gアリル頻度のRA群における有意な増加(P=0.0005,OR=1.60)とc.-306C>T多型、TアリルのSLE群における有意な減少(P=0.005,OR=0.37)が検出された。RAと有意な関連を示したLIR1.EC01/.EC01とLIR5-965G間、SLEと有意な関連を示したLIR6.02とLIR5 c.-306T間にはそれぞれ有意な連鎖不平衡が認められた。そのため、それぞれの多型部位で検出された疾患との有意な関連が、遺伝的に独立なものか遺伝子座間関連解析により検討した。その結果、LIR5-965Gは独立にRA感受性に関与し、LIR1.EC01/.EC01もまたその可能性が高いことが示唆された。一方、SLE感受性においてはLIR5 c.-306Tが一義的な感受性遺伝子でありLIR6.02との関連は連鎖不平衡による二次的なものであることが示唆された。
    RAとの有意な関連が認められた多型によるリガンドとの結合能の変化の有無を調べるために、九州大学生体防御医学研究所ワクチン開発構造生物学分野研究室において研究に従事した。(5月21日〜6月3日、7月15日〜17日、8月18日〜20日)
    日本学術振興会, 特別研究員奨励費, 東京大学, 02J61408
■ Industrial Property Rights